Aims and scope

Molecular Neurodegeneration Advances is an open-access, peer-reviewed journal dedicated to advancing research on neurodegeneration at the molecular, cellular, and systems levels. Our journal focuses on the intricate mechanisms underlying neurodegenerative diseases to inform advanced diagnosis and innovative therapies. These may include clinically and pathologically diagnosed conditions such as Alzheimer's disease and related dementias, Parkinson disease and movement disorders, vascular dementia; pathologically defined conditions such as tauopathies, synucleinopathies, TDP-43 proteinopathies, and other neurodegenerative disorders characterized by protein/peptide aggregation; and acute neurodegenerative conditions such as stroke, traumatic brain injury, and spinal cord injury.

Neurodegenerative diseases pose significant challenges to public health, especially as aging population continues to grow globally. Molecular Neurodegeneration Advances seeks to publish cutting-edge research exploring the molecular pathway, cellular process, pathology, biomarker, state-of-the-art technology, diagnosis, drug discovery, and other advancements that may facilitate the development of more effective treatments and potential cures for these disorders.